Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C

Background and Aims A major barrier to hepatitis C virus (HCV) elimination is the failure to ensure that individuals complete the HCV care cascade after they test positive for HCV RNA and/or antibody. Microelimination programmes support protocols that reengage patients with care/treatment. We descri...

Full description

Saved in:
Bibliographic Details
Published in:Liver international 2025-10, Vol.45 (10), p.e70275-n/a
Main Authors: Buti, Maria, Drenth, Joost P. H., Mendizabal, Manuel, Bittencourt, Paulo L., Metivier, Sophie, Ledinghen, Victor, Reiberger, Thomas, Freyre, Carolina, Rodríguez, Isidoro Narváez, González‐Grande, Rocio, Alados, Juan C., Hernández‐Guerra, Manuel, Dröse, Sandra, Remy, André‐Jean, Morillas, Rosa M., Vera, Francisco, Martin, Paula Moreno, Romero, Gema, Scherbakovsky, Stacey, Hernandez, Candido, Sainz, Maria, Martin, Nicolas J.‐P., Le Blevec, Audrey, Kreter, Bruce, Branch, Andrea D.
Format: Article
Language:English
Subjects:
Adult
Antibodies
antiviral agents
Antiviral Agents - therapeutic use
Best practice
delivery of healthcare
Effectiveness
Female
Hepacivirus - genetics
Hepatitis
Hepatitis C
Hepatitis C - diagnosis
Hepatitis C - drug therapy
Hepatitis C - therapy
Hepatitis C Antibodies - blood
hepatitis C, chronic
Humans
lost to follow‐up
Male
Middle Aged
Patients
Program Evaluation
Prospective Studies
Retrospective Studies
RNA, Viral - blood
vulnerable populations
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!